Search for: "Matter of Lilly"
Results 1 - 20
of 740
Sorted by Relevance
|
Sort by Date
7 Jul 2017, 4:12 am
The culmination of the litigation was heard back in April before the Supreme Court who was tasked with answering this question:"Whether a new pemetrexed based cancer treatment produced by Actavis UK Limited and others infringes Eli Lilly and Company’s patent and its foreign designations either indirectly under s. 60(2) of the Patents Act 1977 (matter for appeal) or directly under a proper interpretation of Article 69 of the Europe Patent Convention 2000… [read post]
1 Oct 2008, 8:46 pm
Eli Lilly is in talks with ImClone Systems about buying the maker of the cancer-fighting drug Erbitux for $6.1 billion, a person briefed on the matter said. [read post]
5 Jan 2012, 5:28 pm
In November 2010, Gemzar, a drug used for treating lung cancer, had its method of use claims invalidated by the US Court of Appeals for the Federal Circuit and its matter of composition claims expired that same month. [read post]
25 Jun 2019, 9:28 am
The icing on the cake was the following on file declaration by a representative of Lilly: “The Applicant seeks to draw a distinction between subject matter which is relevant to the invention which is indicated as being that to which “the present invention generally relates” and “the subject matter provided by the invention”. [read post]
24 Jul 2014, 12:54 pm
Lilly prevailed. [read post]
15 Jun 2011, 6:25 am
We have blogged about the seizure of generic drugs, here.I recently saw an article on the Financial Times.com website which says that Eli Lilly is now settling the matter of seizure of generic drugs with the Indian generic manufacturers.After the initial seizures at Schipol and other European airports, the Indian suppliers had avoided the shipping of generic medicines through European ports. [read post]
3 Apr 2017, 3:45 am
Among the list was Eli Lilly and Actavis. [read post]
10 Apr 2019, 8:00 am
According to the Complaint in this matter, the court found in the previous lawsuit that the filing of NDA No. 208297 indirectly infringed specific claims of the ‘209 patent and entered final judgment in favor of Eli Lilly. [read post]
26 Feb 2020, 2:58 am
Lilly counterclaimed that the divisional patent was invalid (Lilly v Genentech [2020] EWHC 261 (Pat)). [read post]
16 Mar 2018, 12:00 am
The rule’s purpose is to avoid having shareholders considering matters which have already been favorably acted upon. [read post]
13 Apr 2011, 8:14 pm
Lilly v. [read post]
10 Jun 2022, 1:22 pm
“[T]hree people familiar with the matter” informed Reuters of the investigation: the individuals also said that the Federal Bureau of Investigation (FBI) was “participating in the probe. [read post]
11 Jan 2013, 4:00 am
This all seems to be a matter of degree, and context. [read post]
9 Jun 2009, 11:39 am
Sanford Wittels & Heisler, a national civil rights firm with offices in Washington, D.C., New York City and San Francisco, and the Morelli Ratner firm, a New York City-based plaintiff's firm have joined with Rose & Rose, a civil rights firm in Washington, DC, as Co-lead Counsel in the matter. [read post]
22 Sep 2015, 6:37 am
Eli Lilly asked that very question. [read post]
23 May 2019, 1:34 pm
While Petitioners argued the claims were not directed to patentable subject matter, the Court of Appeals found the issue improperly raised. [read post]
20 May 2008, 7:55 am
Below is the real-life story of a Lilly rep who was recently terminated (names have been changed). [read post]
2 Aug 2010, 5:00 am
Eli Lilly and Company (Fed. [read post]
21 Dec 2020, 10:16 am
Eli Lilly and Co v. [read post]
26 Sep 2022, 7:59 pm
According to the EEOC’s suit, in 2017, Lilly’s senior vice president for human resources and diversity recognized at a Leadership Town Hall that Lilly’s workforce was composed of older workers. [read post]
